Gastric secretion

Current Opinion in Gastroenterology

Volumn 24, Issue 6, 2008, Pages 659-664

  Schubert, Mitchell L ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Acid secretion; Gastrin; Helicobacter pylori; Histamine; Hormone; Parietal cell; Peptide

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 1 [2,3 DIHYDRO 1 (2' METHYLPHENACYL) 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL] 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; GASTRIN; GASTRIN RELEASING PEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOCORTICOID; GV 150013; HISTAMINE; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; ITRIGLUMIDE; LEPTIN; OREXIN; PD 135158; POTASSIUM CHANNEL KCNQ1; RPR 101048; UNCLASSIFIED DRUG;

GASTRITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; HELICOBACTER INFECTION; HORMONE ACTION; HUMAN; HYPERGASTRINEMIA; INTESTINE INFECTION; NEUROENDOCRINE SYSTEM; NONHUMAN; PEPTIC ULCER; PROTEIN EXPRESSION; REVIEW; STOMACH PARIETAL CELL; STOMACH SECRETION;

GASTRIC ACID; GASTRIC MUCOSA; GASTRINS; GASTRITIS; HUMANS; STOMACH;

EID: 55749097246     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328311a65f     Document Type: Review

References (61)

1. Dimaline R, Varro A. Attack and defence in the gastric epithelium: a delicate balance. Exp Physiol 2007; 92:591-601. Excellent review of the hormonal and paracrine pathways that contribute to the maintenance of gastric epithelial architecture and secretory function with special emphasis on gastrin.
2. Fock KM, Ang TL, Bee LC, Lee EJD. Proton pump inhibitors: do differences in pharmacokinetics translate into differences in clinical outcomes? Clin Pharmacokinet 2008; 47:1-6.
3. Tucci A, Bisceglia M, Rugge M, et al. Clinical usefulness of gastric juice analysis in 2007: the stone that the builders rejected has become the cornerstone. Gastrointest Endosc 2007; 66:881-890.
4. Checchi S, Montanaro A, Pasqui L, et al. L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies. J Clin Endocrinol Metab 2008; 93:465-469.
5. Centanni M, Gargano L, Canettieri G, et al. Thyroxin in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med 2006; 354:1787-1795.
6. Marco E, Foucaud M, Langer I, et al. Mechanism of activation of a G protein-coupled receptor, the human cholecystokinin-2 receptor. J Biol Chem 2007; 282:28779-28790.
7. Foucaud M, ArcherLahlou E, Marco E, et al. Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin. Regul Peptides 2008; 145:17-23.
8. Grabowska AM, Watson SA. Role of gastrin peptides in carcinogenesis. Cancer Lett 2007; 257:1-15. Excellent review of the potential role of gastrin and its receptor in early carcinogenesis from a group with extensive publications in this area.
9. Lee PT, Liao PC, Chang WC, Tseng JT. Epidermal growth factor increases the interaction between nucleolin and heterogeneous nuclear ribonucleoprotein K/poly(C) binding protein 1 complex to regulate the gastrin mRNA turnover. Mol Biol Cell 2007; 18:5004-5013. Examines the mechanism by which EGF receptor activation regulates gastrin gene expression.
10. Pannequin J, Delaunay N, Buchen M, et al. B-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors. Gastroenterology 2007; 133:1554-1568.
11. PtakBelowska A, Pawlik MW, KrzysiekMaczka G, et al. Transcriptional upregulation of gastrin in response to peroxisome proliferator-activated receptor gamma agonist triggers cell survival pathways. J Physiol Pharmacol 2007; 58:793-801.
12. Subramaniam D, Ramalingam S, May R, et al. Gastrin-mediated interleukin-8 and cyclooxygenase-2 gene expression: differential transcriptional and post-transcriptional mechanisms. Gastroenterology 2008; 134:1070-1082.
13. Steele IA, Dimaline R, Pritchard DM, et al. Helicobacter and gastrin stimulate Reg1 expression in gastric epithelial cells through distinct promoter elements. Amer J Physiol Gastrointest L 2007; 293:G347-G354.
14. Varro A, Kenny S, Hemers E, et al. Increased gastric expression of MMP-7 in hypergastrinemia and significance for epithelial-mesenchymal signaling. Amer J Physiol Gastrointest L 2007; 292:G1133-G1140.
15. Huang H, Ansorge N, Schrader H, et al. The CCK-2/gastrin splice variant receptor retaining intron 4 transactivates the COX-2 promoter in vitro. Regul Peptides 2007; 144:34-42.
16. ElZaatari M, Grabowska AM, McKenzie AJ, et al. Cyclopamine inhibition of the sonic hedgehog pathway in the stomach requires concomitant acid inhibition. Regul Peptides 2008; 146:131-139.
17. +-ATPase expression. The processing is acid dependent and mediated by pepsin A.
18. Orlando LA, Lenard L, Orlando RC. Chronic hypergastrinemia: causes and consequences. Digest Dis Sci 2007; 52:2482-2489.
19. Anlauf M, Perren A, Kloppel G. Endocrine precursor lesions and microadenomas of the duodenum and pancreas with and without MEN1 : criteria, molecular concepts and clinical significance. Pathobiology 2007; 74:279-284.
20. Kloppel G, Anlauf M, Perren A. Endocrine precursor lesions of gastroenter-opancreatic neuroendocrine tumors. Endocr Pathol 2007; 18:150-155.
21. DeBlock CEM, DeLeeuw IH, VanGaal LF. Autoimmune gastritis in type 1 diabetes: a clinically oriented review. J Clin Endocrinol Metab 2008; 93:363-371.
22. Berna MJ, Annibale B, Marignani M, et al. A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors. J Clin Endocrinol Metab 2008; 93:1582-1591.
23. Fossmark R, Jianu CS, Martinsen TC, et al. Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition. Scand J Gastroenterol 2008; 43:20-24.
24. Campana D, Nori F, Piscitelli L, et al. Chromogranin A: is it a useful marker of neuroendocrine tumors? J Clin Oncol 2007; 25:1967-1973.
25. Hirschowitz BI, Worthington J, Mohnen J, Haber M. Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia. Aliment Pharmacol Therapeut 2007; 26:869-878.
26. Cui G, Waldum HL. Physiological and clinical significance of enterochromaffin-like cell activation in the regulation of gastric acid secretion. World J Gastroenterol 2007; 28:493-496.
27. FriisHansen L, Schjerling CK, delaCour CD, et al. Characteristics of gastrin controlled ECL cell specific gene expression. Regul Peptides 2007; 140:153-161.
28. Mettler SE, Ghayouri S, Christensen GP, Forte JG. Modulatory role of phosphoinositide 3-kinase in gastric secretion. Am J Physiol Gastrointest Liver Physiol 2007; 293:G532-G543. In isolated rabbit parietal cells, binding of histamine to the H-2 receptor activates a pathway involving phosphoinositide 3 kinase that diminishes intracellular cyclic AMP and hence may function as a negative feedback pathway under certain circumstances to inhibit histamine-stlmulated acid secretion.
29. Tanaka-Shintani M, Watanabe M. Immunohistochemical study of enterochromaffin-like cell in human gastric mucosa. Pathol Int 2007; 57:572-583.
30. Lambrecht NWG, Yakubov I, Sachs G. Fasting-induced changes in ECL cell gene expression. Physiol Genomics 2007; 31:183-192.
31. Bernsand M, Häkanson R, Norlén P. Tachyphylaxis of the ECL-cell response to PACAP: receptor desensitization and/or depletion of secretory products. Br J Pharmacol 2007; 152:240-248.
32. Kidd M, Modlin IM, Black JW, et al. A comparison of the effects of gastrin, somatostatin, and dopamine receptor ligands on rat gastric enterochromaffin-like cell secretion and proliferation. Regul Peptides 2007; 143:109-117.
33. Jensen RT, Battey JF, Spindel ER, Benya RV. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev 2008; 60:1-42.
34. Baldwin GS, Patel O, Shulkes A. Phylogenetic analysis of the sequences of gastrin-releasing peptide and its receptors: biological implications. Regul Pept 2007; 143:1-14.
35. Kojima M. The discovery of ghrelin: a personal memory. Regul Peptides 2008; 145:2-6.
36. Zhao CM, Furnes MW, Stenstrom B, et al. Characterization of obestatin- and ghrelin-producing cells in the gastrointestinal tract and pancreas of rats: an immunohistochemical and electron-microscopic study. Cell Tissue Res 2008; 331:575-587.
37. Sonmez MF, Ozan E. Determination of ghrelin immunoreactivity in the rat stomach after fasting and refeeding. Acta Histochem 2007; 109:193-199.
38. Yakabi K, Ro S, Onouhi T, et al. Histamine mediates the stimulatory action of ghrelin on acid secretion in rat stomach. Dig Dis Sci 2006; 51:1313-1321.
39. Konturek PC, Brzozowski T, Konturek SJ, et al. Role of histamine in ghrelin-induced gastroprotection against acute gastric lesions, Inflamm Research 2007; 56:S25-S26.
40. Katayama T, Shimamoto S, Oda H, et al. Glucagon receptor expression and glucagon stimulation of ghrelin secretion in rat stomach. Biochem Biophys Res Commun 2007; 357:865-870.
41. De la Cour CD, Björkqvist M, Sandvik AK, et al. A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul Peptides 2001; 99:141-150.
42. Hosoda H, Kangawa K. The autonomic nervous system regulates gastric ghrelin secretion in rats. Regul Peptides 2008; 146:12-18.
43. Seoane LM, AlMassadi O, Barreiro F, et al. Growth hormone and somatostatin directly inhibit gastric ghrelin secretion. An in vitro organ culture system. J Endocrinol Invest 2007; 30:RC22-RC25.
44. Campana D, Nori F, Pagotto U, et al. Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis. Clin Endocrinol 2007; 67:761-766.
45. Checchi S, Montanaro A, Pasqui L, et al. Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies. J Clin Endocrinol Metab 2007; 92:4346-4351.
46. Heinonen MV, Purhonen AK, Makela KA, Herzig KH. Functions of orexins in peripheral tissues. Acta Physiol 2008; 192:471-485.
47. Ehrström M, Gustafsson T, Finn A, et al. Inhibitory effect of exogenous orexin a on gastric emptying, plasma leptin, and the distribution of orexin and orexin receptors in the gut and pancreas in man. J Clin Endocrinol Metab 2005; 90:2370-2377.
48. Ehrström M, Levin F, Kirchgessner AL, et al. Stimulatory effect of endogenous orexin A on gastric emptying and acid secretion independent of gastrin. Regul Peptides 2005; 132:9-16.
49. Lang PA, Schniepp R, Kirchhoff P, et al. PI3 kinase dependent stimulation of gastric acid secretion by dexamethasone. Cell Physiol Biochem 2007; 20:527-534.
50. Sandu C, Artunc F, Grahammer F, et al. Role of the serum and glucocorticoid inducible kinase SGK1 in glucocorticoid stimulation of gastric acid secretion. Pflugers Arch Eur J Physiol 2007; 455:493-503.
51. Cammisotto PG, Gingras D, Bendayan M. Transcytosis of gastric leptin through the rat duodenal mucosa. Am J Physiol Gastrointest Liver Physiol 2007; 293:G773-G779.
52. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007; 87:1409-1439.
53. Larsen PJ, Hoist JJ. Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter. Regul Peptides 2005; 128:97-107.
54. Shin JM, Vagin O, Munson K, et al. Molecular mechanisms in therapy of acid-related diseases. Cell Mol Life Sci 2008; 65:264-281. Review of the chemistry, biologic targets, and pharmacology of proton pump inhibitors.
55. Munson K, Law RJ, Sachs G. Analysis of the gastric H,K ATPase for ion pathways and inhibitor binding sites. Biochemistry USA 2007; 46:5398-5417.
56. Herrmann M, Selige J, Raffael S, et al. Systemic expression profiling of the gastric H+/K+ ATPase in human tissue. Scand J Gastroenterol 2007; 42:1275-1288.
57. +-ATPaSe α-subunit via upregulation of NF-κB.
58. Kanai S, Hosoya H, Ohta M, Miyasaka K. Decreased hydrogen-potassium- activated ATPase (H+-K+-ATPase) expression and gastric acid secretory capacity in aged mice. Arch Gerontol Geriatr 2007; 45:243-252.
59. Heitzmann D, Warth R. No potassium, no acid: K+ channels and gastric acid secretion. Physiology 2007; 22:335-341.
60. Kaufhold M-A, Krabbenhoft A, Song P, et al. Localization, trafficking, and significance for acid secretion of parietal cell Kir4.1 and KCNQ1 K+ channels. Gastrenterology 2008; 134:1058-1069.
61. Kosiek O, Busque SM, Foller M, et al. SLC26A7 Can function as a chloride-loading mechanism in parietal cells. Pflugers Arch Eur J Physiol 2007; 454: 989-998.